Home LiteratureArticle Details
PMID: 17942673 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Distinctive patterns of microRNA expression in primary muscular disorders.

Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, Amato AA, Lidov HG, Kang PB, North KN, Mitrani-Rosenbaum S, Flanigan KM, Neely LA, Whitney D, Beggs AH, Kohane IS, Kunkel LM

Abstract

The primary muscle disorders are a diverse group of diseases caused by various defective structural proteins, abnormal signaling molecules, enzymes and proteins involved in posttranslational modifications, and other mechanisms. Although there is increasing clarification of the primary aberrant cellular processes responsible for these conditions, the decisive factors involved in the secondary pathogenic cascades are still mainly obscure. Given the emerging roles of microRNAs (miRNAs) in modulation of cellular phenotypes, we searched for miRNAs regulated during the degenerative process of muscle to gain insight into the specific regulation of genes that are disrupted in pathological muscle conditions. We describe 185 miRNAs that are up- or down-regulated in 10 major muscular disorders in humans [Duchenne muscular dystrophy (DMD), Becker muscular dystrophy, facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophies types 2A and 2B, Miyoshi myopathy, nemaline myopathy, polymyositis, dermatomyositis, and inclusion body myositis]. Although five miRNAs were found to be consistently regulated in almost all samples analyzed, pointing to possible involvement of a common regulatory mechanism, others were dysregulated only in one disease and not at all in the other disorders. Functional correlation between the predicted targets of these miRNAs and mRNA expression demonstrated tight posttranscriptional regulation at the mRNA level in DMD and Miyoshi myopathy. Together with direct mRNA-miRNA predicted interactions demonstrated in DMD, some of which are involved in known secondary response functions and others that are involved in muscle regeneration, these findings suggest an important role of miRNAs in specific physiological pathways underlying the disease pathology.

MeSH Terms
Cluster Analysis Gene Expression Regulation Humans MicroRNAs/genetics Muscular Dystrophies/genetics,pathology Oligonucleotide Array Sequence Analysis Principal Component Analysis RNA, Messenger/genetics,metabolism Reproducibility of Results Signal Transduction
Chemicals
MicroRNAs RNA, Messenger
Authors & Affiliations
16 authors, click to expand affiliations / ORCID
Eisenberg Iris
Howard Hughes Medical Institute, Program in Genomics, Division of Genetics, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Eran Alal
Nishino Ichizo
Moggio Maurizio
Lamperti Costanza
Amato Anthony A
Lidov Hart G
Kang Peter B
North Kathryn N
Mitrani-Rosenbaum Stella
Flanigan Kevin M
Neely Lori A
Whitney Duncan
Beggs Alan H
Kohane Isaac S
Kunkel Louis M
References (40)
40 references, click to expand
  1. MicroRNA functions in animal development and human disease.
    Development. 2005 Nov;132(21):4653-62 PMID: 16224045
  2. The diverse functions of microRNAs in animal development and disease.
    Dev Cell. 2006 Oct;11(4):441-50 PMID: 17011485
  3. DAVID: Database for Annotation, Visualization, and Integrated Discovery.
    Genome Biol. 2003;4(5):P3 PMID: 12734009
  4. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle.
    Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15000-5 PMID: 12415109
  5. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes.
    RNA. 2005 Mar;11(3):241-7 PMID: 15701730
  6. Dysferlin and the plasma membrane repair in muscular dystrophy.
    Trends Cell Biol. 2004 Apr;14(4):206-13 PMID: 15066638
  7. Muscle-specific microRNA miR-206 promotes muscle differentiation.
    J Cell Biol. 2006 Aug 28;174(5):677-87 PMID: 16923828
  8. Limb-girdle muscular dystrophies--from genetics to molecular pathology.
    Neuropathol Appl Neurobiol. 2004 Apr;30(2):91-105 PMID: 15043707
  9. Control of stress-dependent cardiac growth and gene expression by a microRNA.
    Science. 2007 Apr 27;316(5824):575-9 PMID: 17379774
  10. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis.
    Nature. 2005 Jul 14;436(7048):214-20 PMID: 15951802
  11. Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth.
    Genes Dev. 2005 Oct 1;19(19):2343-54 PMID: 16166373
  12. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy.
    Neurology. 2003 Mar 25;60(6):993-7 PMID: 12654966
  13. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling.
    Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):18986-91 PMID: 16357195
  14. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A.
    Nat Med. 1999 May;5(5):503-11 PMID: 10229226
  15. Characterization of microRNA expression profiles in normal human tissues.
    BMC Genomics. 2007 Jun 12;8:166 PMID: 17565689
  16. An optimized isolation and labeling platform for accurate microRNA expression profiling.
    RNA. 2005 Sep;11(9):1461-70 PMID: 16043497
  17. Accumulation of miR-155 and BIC RNA in human B cell lymphomas.
    Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3627-32 PMID: 15738415
  18. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing.
    J Biol Chem. 2003 Dec 12;278(50):50466-73 PMID: 14506282
  19. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A.
    Cell. 1995 Apr 7;81(1):27-40 PMID: 7720071
  20. Facioscapulohumeral muscular dystrophy.
    Muscle Nerve. 2006 Jul;34(1):1-15 PMID: 16508966
  21. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.
    Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11755-60 PMID: 15284443
  22. Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle.
    Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4666-71 PMID: 12677001
  23. RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy.
    Acta Neurol Scand. 2007 Feb;115(2):115-21 PMID: 17212615
  24. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.
    Genomics. 1988 Jan;2(1):90-5 PMID: 3384440
  25. Molecular profiles of inflammatory myopathies.
    Neurology. 2002 Oct 22;59(8):1170-82 PMID: 12391344
  26. Requirement of bic/microRNA-155 for normal immune function.
    Science. 2007 Apr 27;316(5824):608-11 PMID: 17463290
  27. Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies.
    Nat Clin Pract Rheumatol. 2006 Apr;2(4):219-27 PMID: 16932688
  28. A single-molecule method for the quantitation of microRNA gene expression.
    Nat Methods. 2006 Jan;3(1):41-6 PMID: 16369552
  29. MicroRNA-155 is induced during the macrophage inflammatory response.
    Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1604-9 PMID: 17242365
  30. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy.
    J Clin Invest. 2007 Apr;117(4):889-901 PMID: 17380205
  31. Clarifying the boundaries between the inflammatory and dystrophic myopathies: insights from molecular diagnostics and microarrays.
    Rheum Dis Clin North Am. 2002 Nov;28(4):743-57 PMID: 12506770
  32. Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2.
    Am J Hum Genet. 2007 Jan;80(1):162-7 PMID: 17160903
  33. MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206.
    J Cell Biol. 2006 Oct 9;175(1):77-85 PMID: 17030984
  34. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation.
    Nat Genet. 2006 Feb;38(2):228-33 PMID: 16380711
  35. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology.
    J Cell Biol. 2000 Dec 11;151(6):1321-36 PMID: 11121445
  36. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
    Hum Mol Genet. 2003 Nov 15;12(22):2895-907 PMID: 14519683
  37. MicroRNAs: genomics, biogenesis, mechanism, and function.
    Cell. 2004 Jan 23;116(2):281-97 PMID: 14744438
  38. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.
    Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6 PMID: 16885212
  39. Molecular mechanisms of muscular dystrophies: old and new players.
    Nat Rev Mol Cell Biol. 2006 Oct;7(10):762-73 PMID: 16971897
  40. Signaling pathways in skeletal muscle remodeling.
    Annu Rev Biochem. 2006;75:19-37 PMID: 16756483
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2007-10-23
Epub
2007-00-17
Pages
17016-21
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC2040449
Subset
IM
Grants
NIAMS NIH HHS · R01 AR044345-11 · United States
NIAMS NIH HHS · R01 AR044345 · United States
NIAMS NIH HHS · R01 AR044345-10 · United States
NIAMS NIH HHS · R01 AR 044345 · United States
NCRR NIH HHS · M01 RR 00064 · United States
NCRR NIH HHS · M01 RR000064 · United States
Telethon · GTF02008 · Italy
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com